Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FWGA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,394
Award facts
- Contract value 100% obligated
- $19,394.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,394.48 to AmerisourceBergen Drug Corp for Beyfortus 100 mg/ml syringes on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated extensive capability in fulfilling federal medical procurement requirements through competitive awards with the Defense Logistics Agency's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Beyfortus is a monoclonal antibody immunization product used for respiratory syncytial virus (RSV) prevention, particularly in vulnerable populations, making this delivery order part of the critical medical commodities supplied under the broader DLA pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DR26FWGA9?
SPE2DR26FWGA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FWGA9 worth?
The government has obligated $19,394 on SPE2DR26FWGA9.
Is contract SPE2DR26FWGA9 an order under another contract?
Yes. SPE2DR26FWGA9 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWGA9 competed?
The extent of competition for SPE2DR26FWGA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award